VERIPHARM
ActiveSummary
VERIPHARM has been active since 2001 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €885k and a net result of €185k. Equity is growing by ~3.1% per year across the filed fiscal years. Its solvency ranks better than 63% of 2284 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
Checked score
Credit check for your own amount and term
Signals
Checked, nothing found (2)
Financials · fiscal year 2025, abbreviated schema
Filed annual accounts As filed with the NBB · 2025 against 2024 · 52 lines
The notes to these accounts (5 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €95k | €103k | €99k | €100k | €97k | ▼ 3.6% |
| Other operating charges640/8 | €14k | €14k | €8k | €13k | €11k | ▼ 15.0% |
| Gross operating margin9900 | €193k | €133k | €179k | €163k | €170k | ▲ 4.8% |
| Operating profit (loss)9901 | €85k | €16k | €71k | €49k | €63k | ▲ 27.0% |
| Financial income75/76B | €56k | €18k | €10k | €20k | €173k | ▲ 784% |
| Recurring financial income75 | €18k | €18k | €10k | €20k | €9k | ▼ 56.2% |
| Non-recurring financial income76B | €38k | - | - | - | €164k | - |
| Financial charges65/66B | €19k | €13k | €16k | €24k | €27k | ▲ 12.6% |
| Recurring financial charges65 | €19k | €13k | €16k | €24k | €27k | ▲ 12.6% |
| Profit (loss) for the period before taxes9903 | €122k | €21k | €65k | €45k | €208k | ▲ 366% |
| Income taxes67/77 | €21k | €3k | €16k | €8k | €23k | ▲ 173% |
| Profit (loss) for the period9904 | €102k | €18k | €49k | €36k | €185k | ▲ 411% |
| Transfer from tax-exempt reserves789 | €816 | - | - | - | - | - |
| Profit (loss) for the period to be appropriated9905 | €103k | €18k | €49k | €36k | €185k | ▲ 411% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €2.20M | €2.13M | €2.04M | €1.99M | €1.55M | ▼ 22.3% |
| Fixed assets21/28 | €1.44M | €1.44M | €1.37M | €1.31M | €1.21M | ▼ 7.4% |
| Tangible fixed assets22/27 | €1.44M | €1.44M | €1.37M | €1.31M | €1.21M | ▼ 7.4% |
| Land and buildings22 | €1.43M | €1.43M | €1.37M | €1.29M | €1.20M | ▼ 7.3% |
| Plant, machinery and equipment23 | €419 | €336 | €252 | €14k | €13k | ▼ 11.1% |
| Furniture and vehicles24 | €8k | €3k | €2k | €1k | €964 | ▼ 33.3% |
| Current assets29/58 | €768k | €694k | €668k | €687k | €340k | ▼ 50.5% |
| Amounts receivable after more than one year29 | €172k | €117k | €60k | - | - | - |
| Other amounts receivable291 | €172k | €117k | €60k | - | - | - |
| Amounts receivable within one year40/41 | €83k | €87k | €130k | €228k | €259k | ▲ 13.5% |
| Trade receivables40 | €30k | €22k | €39k | €90k | €90k | ▲ 0.7% |
| Other amounts receivable41 | €53k | €65k | €92k | €139k | €169k | ▲ 21.8% |
| Current investments50/53 | €325k | €333k | €335k | €350k | €5k | ▼ 98.5% |
| Cash at bank and in hand54/58 | €138k | €157k | €143k | €109k | €75k | ▼ 31.0% |
| Deferred charges and accrued income490/1 | €50k | - | - | - | - | - |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €2.20M | €2.13M | €2.04M | €1.99M | €1.55M | ▼ 22.3% |
| Equity10/15 | €1.20M | €1.18M | €1.23M | €700k | €885k | ▲ 26.4% |
| Contributions10/11 | €262k | €262k | €262k | €262k | €262k | = |
| Capital10 | €262k | €262k | €262k | €262k | €262k | = |
| Issued capital100 | €262k | €262k | €262k | €262k | €262k | = |
| Reserves13 | €935k | €923k | €973k | €439k | €624k | ▲ 42.1% |
| Non-distributable reserves130/1 | €26k | €26k | €26k | €26k | €26k | = |
| Legal reserve130 | €26k | €26k | €26k | €26k | €26k | = |
| Distributable reserves133 | €909k | €897k | €947k | €413k | €598k | ▲ 44.8% |
| Amounts payable17/49 | €1.01M | €947k | €802k | €1.29M | €664k | ▼ 48.6% |
| Amounts payable after more than one year17 | €870k | €794k | €718k | €652k | €594k | ▼ 8.9% |
| Financial debts170/4 | €870k | €794k | €718k | €652k | €594k | ▼ 8.9% |
| Amounts payable within one year42/48 | €135k | €150k | €83k | €640k | €68k | ▼ 89.4% |
| Current portion of amounts payable after more than one year42 | €76k | €76k | €76k | €66k | €58k | ▼ 11.4% |
| Trade debts44 | €323 | €247 | €2k | €2k | €1k | ▼ 27.4% |
| Suppliers440/4 | €323 | €247 | €2k | €2k | €1k | ▼ 27.4% |
| Taxes, remuneration and social security45 | €11k | €5k | €4k | €3k | €9k | ▲ 217% |
| Taxes450/3 | €11k | €5k | €4k | €3k | €4k | ▲ 37.8% |
| Remuneration and social security454/9 | - | - | - | - | €5k | - |
| Other amounts payable47/48 | €48k | €69k | €652 | €570k | - | - |
| Accrued charges and deferred income492/3 | €2k | €3k | €1k | €1k | €2k | ▲ 72.0% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €102k | €18k | €49k | €36k | €185k | ▲ 411% |
| + Depreciation and write-downs630 | €95k | €103k | €99k | €100k | €97k | ▼ 3.6% |
| Operating cash flow (approximation) | €196k | €121k | €149k | €137k | €282k | ▲ 106% |
| Investment in fixed assets (approximation) | - | €-104k | €-30k | €-38k | €0 | ▲ 100% |
| Change in cash | - | €19k | €-14k | €-34k | €-34k | ▼ 0.6% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Show earlier events
About the unread acts
We know of 5 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Directors · office · real estate
1 establishment unit
1 parcel
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 13025G1085/00Z009 | Flanders | 1,005 m² | 1 · 217 m² | 10.4 m · 2 fl. |
Linked by address, not proof of ownership
Similar companies · same sector, comparable size
Identification & contact
Scores and ratios are computed by Checked and are not a credit decision.